Jones Financial Companies’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18
Closed -$73 4040
2025
Q1
$73 Buy
18
+8
+80% +$48 ﹤0.01% 3640
2024
Q4
$83 Buy
+10
New +$87 ﹤0.01% 3363
2021
Q1
Sell
-2
Closed -$1K 785
2020
Q4
$1K Buy
+2
New +$1.27K ﹤0.01% 642

Other funds holding BLUE

Jones Financial Companies's BLUE Position: Q2 2025 in Review

Jones Financial Companies sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 18 shares — an estimated $73 sold.

Jones Financial Companies first reported a position in BLUE in Q4 2020 and held it in 3 quarters. The position peaked at $1K in Q4 2020. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Jones Financial Companies reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Jones Financial Companies sold 18 bluebird bio shares in Q2 2025, an estimated $73.
  • Jones Financial Companies first reported a position in bluebird bio in Q4 2020 and held it in 3 quarters.
  • Jones Financial Companies's bluebird bio position peaked at $1K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Jones Financial Companies's 13F filing for Q2 2025, filed 13 Aug 2025.